De missie van Noaber vatten we samen in: driving change, improving health. Met onze programma's en participaties streven we een maximale impact na: verbeteringen wat betreft gezondheid en het ervaren van zorgkwaliteit, een verbeterde beleving door de professional en vermindering van zorgkosten (quadruple aim).

Anadea is a global software development company with over 20 years of experience delivering innovative solutions across industries. Since 2000, we’ve been designing, building, upgrading, and maintaining software that drives growth and solves complex business challenges. Industries we serve: - Education: LMS platforms, eLearning solutions, and educational apps. - Healthcare: EMR/EHR systems, practice management software, telemedicine platforms, and medical apps. - Real Estate: Property marketplaces, management tools, and collaboration platforms. - E-commerce: Online retail portals, loyalty programs, and custom eCommerce solutions. - Fintech: Investment platforms, loan marketplaces, and personal finance apps. - Retail: Inventory management, supply chain solutions, demand forecasting, and vendor management systems. - Travel: Booking engines, travel apps, and online travel portals. - Sports: Team management platforms and coaching software. We’re passionate about what we do and always open to new ideas. If you’re ready to bring your project to life, let’s talk and see how we can make it happen together.

Real-Time Innovations (RTI) is the software framework company for physical AI systems, with a mission to run a smarter world. RTI Connext® provides the data architecture for over 2,000 designs in Aerospace and Defense, Medtech, Automotive, and Robotics – running in more than $1T of total deployed systems worldwide. Only RTI combines decades of technical expertise with industry-leading software and tools to develop smarter systems, faster.

Medicash has provided first-class health plans to businesses and families for over 150 years. Committed to the importance of staying fit and healthy, we’ve made it our business to provide the leading choice in positive health plans and actively encourage our members to take better care of themselves through a range of groundbreaking initiatives. Today we offer a choice of health plans that can be implemented as either part of a company-paid benefit package, part of a flexible benefits scheme or offered as a voluntary benefit to employees. Having pioneered innovative healthcare insurance solutions for 150 years, our approach to business is simple yet dynamic, as we respond to a fast-changing market by investing in research and product development. Recognising that prevention is better than cure, we actively encourage healthy living and place great importance on health screening. We also understand that for many people, financial help towards regular dental treatment and optical care is a major benefit, so our plans are structured to assist with the cost of everyday health issues and complementary therapies as well as illness and injury. With the peace of mind of having one of Britain’s most experienced cash plan providers by your side; you can be positive that Medicash is the right choice for you and your business.

Wir engagieren uns dafür, dass sich Zürcher KMU mit ihren Innovationspotenzialen auseinandersetzen und diese auch initial angehen, um wettbewerbsfähig zu bleiben. Dies mit der Innovationsberatung (vormals KMU und INNOVATION), die seit 1. September 2025 durch die Folgeorganisation Ahead – Gründungs- und Innovationszentrum erbracht wird. Über diesen Auftritt informieren wir nun über den Zürcher KMU Innovationstag und begleitende Aktivitäten.

Operator of private health and travel insurance services designed to provide comprehensive coverage options. The company offers a range of insurance products, including private health insurance, dental supplementary insurance, hospital supplementary insurance, and travel insurance, serving individuals and families. With over 90 years of experience, the entity leverages digital services to streamline claims processing and enhance customer management.

At MAPFRE, we’re committed to protecting what matters most to you. That’s why we’re the largest Spanish-owned insurer in the world, the largest multinational insurance company in Latin America and among the 15 largest European groups by premium volume. With a legacy spanning more than 90 years, we’re proud to provide innovative insurance and service solutions to protect people and companies around the world. Our purpose is to be by your side, accompanying you to move forward with peace of mind, contributing to the development of a more sustainable and caring society, while our global footprint enables us to guarantee solvency, promote innovation, and provide the best service, all the while acting with the utmost integrity. At MAPFRE, we believe in the power of people. Our multicultural and diverse team is the driving force behind our success, bringing our vision and mission to life, contributing their talent, passion and experience day after day. If you want to learn more about MAPFRE, please visit our website or the Life in the Company section here. Welcome to MAPFRE!

Amino Collective’s primary investment focus lies within the realms of health and bio. We help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. We invest in early-stage ventures that have a European focus and the ambition to scale globally.

Withings Health Solutions is a dedicated division of connected health leader Withings, serving healthcare professionals across chronic disease prevention and management, remote patient monitoring, clinical research, and more. Its mission is to remove the complexity out of running digital health programs, so care teams can focus on what they do best: taking care of their patients. The Withings portfolio includes connected scales, blood pressure monitors, an advanced sleep system, a smart temporal thermometer and hybrid smartwatches. It also includes data connectivity options as well as a remote patient monitoring platform. For more than a decade, Withings has built an expertise in user experience, engagement and retention.

Chino.io helps companies dealing with sensitive data to give the right answers to data protection questions they receive from clients, regulators, and investors. We are specialised in GDPR, HIPAA, DVG/DiGA, NHS, and others, and we work with digital health, AI, and blockchain applications.

HERAN PARTNERS is a Belgian-based investment fund founded by Annie Vereecken together with Katleen Vandersmissen, Joris Mortelmans and Herman Verrelst within the sector of MedTech and Digital Health. With a clear focus on European HealthTech, the fund provides venture & growth capital accompanied by a strong network, expertise and mentorship to startups and scale-ups with a strong technology platform and market potential. We strive to have impact!

Within Gruppo San Donato we are a clinical, scientific and university centre of high specialization, since 1971. Our mission of medical and scientific excellence stems from our three-pronged identity. We are a place where Research, Medicine and University Education all meet and work together each and every day. We meet challenges, thanks to our experts who combine their skills to benefit people. Because there is no cure without research.

FirstWord Pharma supplies global news and intelligence to the pharmaceutical industry. The service provides the top industry news stories on a daily basis in a format that is quick and easy to access so that users can always be in-the-know about the latest news and developments in their industry.

bmp is a venture capital firm based in Berlin and Magdeburg. We have been committed to support exceptional entrepreneurs build successful companies. We look for companies that create sustainable and profitable businesses. Our successful exits include komoot, calimoto, home power solutions, flightright, uninow, mbr targeting, market logic software and pure systems. The current portfolios contain companies such as Coman Software, Silicon Radar, OXID eSales, TesVolt, Solar Materials, Immunic and vivoryon.

NextGen Venture Partners works with over 1,800 Venture Partners to invest $1 million in seed stage companies and $2 million to $10 million in companies with more than $10 million in revenue. Our Venture Partners are top founders and innovation executives across the country whose expertise and connections help NextGen accelerate the growth of our portfolio companies.

Parenthood looks different here.

Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research. Huma’s technology has powered over 3,000 hospitals and clinics, with 500+ unique deployments across 70+ countries. The software has been used to engage and screen over 35 million individuals, with 1.8 million active users across its various products. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as working with most large pharma companies and CROs. The Huma Cloud Platform offers a technology infrastructure built on strong regulatory foundations to launch digital solutions for healthcare and research. Huma has achieved FDA 510(k) Class II, EU/MDR Class IIb, and Saudi FDA Class C regulatory clearance for its disease-agnostic flagship product, enabling rapid, code-free configuration with the ability to host AI/ML models.

ActiTrexx GmbH is a new biotech start up and was founded in 2020. Our vision is to offer a curative cellular therapy to prevent inflammatory reactions in conditions like GvHD, solid organ transplantation and autoimmune diseases. Regulatory T cells (Treg) - natural guardian cells of the immune system - are the key players of our cell-based drug product. Isolated Treg are activated ex vivo via specific methods and administered to patients intravenously. Unlike other comparable approaches, activated Treg (ATreg) will not be expanded in vitro, protecting them against a possible loss of function. Thus, ATreg is a safe and efficient treatment option for transplanted patients preventing and providing substantial decrease of GvHD severity and related mortality as well. The founders of ActiTrexx GmbH combine many years of unique experience in basic research, biotechnology, clinical application and pharmaceutical development. The management team is supported and complemented by a strong network of collaborators, advisors and key opinion leaders as well as experienced managers. ActiTrexx GmbH is headquartered in Mainz, Germany.

In MiMARK, we care for women's health. We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients. Abnormal uterine bleeding affects 14M between women in EU and US yearly (in women between 50 and 75 years old). Diagnosis of endometrial cancer is mandatory for all those women as 10% of those will be diagnosed with the disease. Current diagnosis is based on the pathological examination of an endometrial biopsy (pipelle biopsy), but this fails to diagnose in up to 30% of patients, and provides an inaccurate diagnosis in up to 55% of cases. This failure is associated to the scarce cellularity of the sample. In those cases, invasive diagnosis using histeroscopy needs to be performed. Our solution: WomEC. It is an in vitro diagnostic tool based on the determination of 5 protein biomarkers in uterine fluid samples to provide diagnosis to 100% of patients, rule out endometrial cancer with great specificity, and provide information on histological subtype of the tumor to guide surgical treatment.

We are a European headquartered hub for litigation, transactions and advice throughout the world and have remained fiercely independent since we first began in 1837. This means we are free to partner with the best people in any jurisdiction for each client need, or work with your existing relationships. We don’t work to billing targets. This ensures you get the right combination of experts working as one, who take the time to share their different perspectives and find the right answer, no matter how difficult or novel the question is. It’s a rare approach that defines the quality of our advice. And because we like to recruit inquisitive minds, many with science and technology backgrounds, we live and breathe your business, can talk the same language and have a keen eye on the future. We enjoy getting to the heart of the matter with advice that is simple to understand and easy to use. Like any business we have evolved with time, but our focus and spirit have remained as resolute as the quality of our advice and as inimitable as the experience we deliver. We are Bristows, seeing things differently for those shaping tomorrow.

Founded to find a cure for a daughter’s rare disease, United Therapeutics is a biotechnology company transforming care for people with chronic and life-threatening conditions. Our purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. We are bold and unconventional. We have fun, we do good. We are also the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation.

We are hired to help organizations establish lean processes, modernize technology, and implement enterprise-wide web-based applications using IoT, MVC, and open source databases. We build tools to effectively and efficiently collect, analyze and summarize data. Headquartered in the Washington DC area, we are WOSB certified, amd hold DBE and MBE certifications in 14 states. We have international offices and partnering relationships in Colombia, Ecuador, Peru, El Salvador, and the UK, for the last 20 years. We have long standing agreements and engagements with experienced international consultants experienced with monitoring, evaluation and capacity building projects in the World Bank, UNDP, USAID and US Department of State. Members of the Small Business Association of International Consultants. AQUAS was established in 1990, owned and operated by Carmen Larsen, a Physics graduate of Georgetown University. AQUAS services have focused in Bioethics Case Management, Healthcare, Agriculture and Transportation industries primarily in the public sector.

REconomistas Community of Practice is a trans-local network providing peer-to-peer support to entrepreneurs and enterprise ecosystem builders that are reimagining how we can meet our needs, create livelihoods and jobs in ways that are inclusive, socially and ecologically regenerative, fair and resilient. A REconomy Enterprise is a financially viable trading entity that fulfils a real community need, delivers social benefits and has beneficial, or at least neutral, environmental impacts. We are closely linked with Transition movement. We practice Permaculture Ethics and follow Modern Agile principles in the way we work: - Make people awesome - Make safety a prerequisite - Experiment and learn rapidly - Deliver value continuously

Sofia Angels Ventures is a € 13 million venture capital fund backed up by the European Investment Fund to co-invest alongside angels, family offices and other private investors and funds. We focus on technology startups at pre-seed & seed stage predominantly from Bulgaria, SEE & CEE countries but with a vision to operate around Europe and Globally. Sofia Angels Ventures is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.

Patients should only undergo medical procedures that are meaningful and necessary. No woman should have unjustified worries about getting cervical cancer and every cancer patient is taken care off with effective treatment protocols only. Our first product, the CervicaDx test, will prevent overdiagnosis and overtreatment of women, participating in cervical cancer screening programs, by detecting cervical aberrations before they can develop into cancer, with much higher specificity than is currently feasible.